Lifecore Biomedical to be acquired by Webster Equity Partners in deal worth up to $663.7M

Lifecore Biomedical is being acquired by Webster Equity Partners in a transaction valued at up to $663.7M. Stockholders may receive up to $9.67 per common equivalent in combined cash and contingent value right (CVR) payments at full performance milestones.

Detected & updated continuously · Source: Nebula